4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-20-054727
Chief Medical Officer sold 52,906 shares at an average $40.74 ($2,155,603)
- Chief Medical Officer acquired 52,906 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2020-10-08 | Option exercise | +22,906 | $5.28 | $120,944 | 189,523 | I |
| Ho Carole Chief Medical Officer | 2020-10-08 | Sale | −22,906 | $40.12 | $918,989 | 166,617 | I |
| Ho Carole Chief Medical Officer | 2020-10-09 | Option exercise | +30,000 | $5.28 | $158,400 | 196,617 | I |
| Ho Carole Chief Medical Officer | 2020-10-09 | Sale | −10,465 | $40.68 | $425,716 | 186,152 | I |
| Ho Carole Chief Medical Officer | 2020-10-09 | Sale | −19,535 | $41.51 | $810,898 | 166,617 | I |
| Derivatives | |||||||
| Ho Carole Chief Medical Officer | 2020-10-08 | Option exercise · Stock Option (right to buy) | −13,020 | 44,035 | D | ||
| Ho Carole Chief Medical Officer | 2020-10-08 | Option exercise · Stock Option (right to buy) | −9,886 | 68,240 | D | ||
| Ho Carole Chief Medical Officer | 2020-10-09 | Option exercise · Stock Option (right to buy) | −30,000 | 38,240 | D | ||
| Open-market sales · 52,906 sh · avg $40.74 · $2,155,603 | |||||||
Loading xslF345X03/doc4.xml…